Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Haematologica|March 26, 2026
MLL-AF9 expression levels do not instruct lineage fateEmmanouil Kyrloglou, Marco Carretta, Annet Brouwers-Vos, et al.
Experimental Hematology|May 1, 2017
Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft modelsMarco Carretta, Bauke de Boer, Jenny Jaques, et al.
Elife|June 15, 2019
Protein quality control in the nucleolus safeguards recovery of epigenetic regulators after heat shockMaria Azkanaz, Aida Rodríguez López, Bauke de Boer, et al.
Blood Advances|September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clonesRoos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Molecular & Cellular Proteomics : MCP|May 7, 2025
Quantitative Label-Free Single-Cell Proteomics on the Orbitrap Astral MSValdemaras Petrosius, Pedro Aragon-Fernandez, Tabiwang N Arrey, et al.
Nature Communications|March 2, 2022
The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemiaAyşegül Erdem, Silvia Marin, Diego A Pereira-Martins, et al.
Leukemia|January 11, 2023
The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genesMette Louise Trempenau, Mikkel Bruhn Schuster, Sachin Pundhir, et al.
Blood|October 14, 2016
Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based nichesAntonella Antonelli, Willy A Noort, Jenny Jaques, et al.
Cancer Cell|September 25, 2018
Prospective Isolation and Characterization of Genetically and Functionally Distinct AML SubclonesBauke de Boer, Janine Prick, Maurien G Pruis, et al.
Pageof 1